VEGFA and wet macular degeneration: The release of VEGF is known to mediate the abnormal angiogenesis seen in wet AMD, and long-term anti-VEGF therapy has remained the gold standard treatment to control choroidal neovascularization in patients with wet AMD for decades [27,28].